Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT02626546 |
Other study ID # |
2015/1128-31/4 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
November 2015 |
Est. completion date |
September 2020 |
Study information
Verified date |
September 2021 |
Source |
Karolinska Institutet |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
This is a multicentre, prospective, observational cohort study. Consecutive patients,
operated in six University Hospitals in Sweden will be recruited following major surgical
procedure. The length of patient recruitment period will be 12 weeks. The length of follow up
will be 360 days . The objectives are to determine the postoperative morbidity (during the
hospital stay), the survival (0-360 days), to identify risk factors for adverse outcomes and
to identify risk factors that may potentially be influenced by any intervention in the
future.
Amendments:
1. The follow-up of mortality is extended to 3 years of the cohort
2. The mortality of the background population at 30 and 90 Days will be analyzed
3. Validation of the Surgical Outcome Risk Tool in the study cohort and in the background
population are planned
Description:
This is a multicenter, prospective, observational study. Length of patient recruitment is 12
weeks, the length of observation is 360 postoperative days. The expected number of patients
is 1000.
Patients will be selected from the operation planning software on each study site. It is done
by daily screening of the operation list and will be enrolled by applying the inclusion
criteria. The criteria of surgical severity will be assessed by the UK surgical severity
grading system ( AXA PPP/ Specialist Procedure Codes, United Kingdom). For that purpose a
scroll list will be used, which is available on the website of the Surgical Outcome Risk Tool
calculator.
Patient characteristics will be prospectively collected from medical records: age, gender,
co-morbidities, medical history, physical activity, blood pressure, heart rate, oxygen
saturation and neurological function; routine laboratory findings; type, complexity, urgency
of surgery, incision localization and malignancy; lowest intraoperative systolic blood
pressure, heart rate. The outcomes are the postoperative morbidity (assessed by the
Postoperative Morbidity Survey) classified by the Clavien-Dindo classification tool (during
hospital stay), and mortality, use of medications, hospital re-admissions (0-360 days) and
new occurrence in different disease related national quality registries.Relationships between
postoperative morbidity (POMS) the severity of morbidity (Clavien Dindo) and mortality will
be analyzed. For illustration, Kaplan Meyer plots will be used, and for analyses Cox
proportional hazard model will be used with adjustment for sex and age.
Additional changes:
1. The length of observation for survival was extended to 3 years. The mortality at 3 years
will be analyzed addressing the relationship between the postoperative morbidity (POMS)
and mortality. Cox regression model will be used with adjustment of age, comorbidity and
malignancy.
2. Validation of Surgical Outcome Risk Tool is planned in two populations related to the
PROFS study: eligible and background population. As the PROFS cohort was manually
selected, we presumed that the eligible population is larger than the enrolled
population.To enable electronic selection of the eligible population, we have developed
a script, which translates the Swedish surgical codes into the UK severity codes. Using
the same script we will classify the surgical severity in the background population of
the PROFS cohort. Variables included in the Surgical Outcome Risk Tool will be extracted
from the operation databases of each study site. The date of death will be extracted
from the Swedish National Adress Registry and the malignancy from the registry of
National Swedish Cancer Registry.